MultiCell Immunotherapeutics, Inc. and Oxis Biotech, Inc. patent, know-how and technology license agreement | Practical Law
MultiCell Immunotherapeutics, Inc. and Oxis Biotech, Inc. patent, know-how and technology license agreement
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
MultiCell Immunotherapeutics, Inc. and Oxis Biotech, Inc. patent, know-how and technology license agreement
MultiCell Immunotherapeutics, Inc. and Oxis Biotech, Inc. patent, know-how and technology license agreement
March 10, 2015
•
License Agreements
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.
Back to top